[INHALED ANTIBIOTICS IN TREATMENT OF NOSOCOMIAL PNEUMONIA]
Anesteziologiia I Reanimatologiia
|November 25, 2015
Abstract:
Nosocomial pneumonia is the most common infection in intensive care units. Currently the problem of resistance of noso-comial pathogens to miost of antibiotics is crucial. Using of inhaled antibiotics in combination with intravenous drugs is eff ective and safe method for treatment of nosocomial pneumonia. The literature review describes current opportunities of ihhaled antibiotic therapy of nosocomial pneumonia, descriptions of drugs, the advantages and disadvantages of this treatment. Special attention is paid for using inhaled aminoglycosides for nosocomial pneumonia.
Insights
Inhaled antibiotics offer an effective and safe treatment for nosocomial pneumonia, especially when combined with intravenous drugs. This approach addresses the critical issue of antibiotic resistance in intensive care units.
Area of Science:
- Infectious Diseases
- Pulmonology
- Critical Care Medicine
Context:
- Nosocomial pneumonia is a prevalent infection in intensive care units (ICUs).
- Rising antibiotic resistance among nosocomial pathogens poses a significant clinical challenge.
- Intravenous antibiotic therapy alone may be insufficient for treating severe ICU-acquired infections.
Purpose:
- To review the current landscape of inhaled antibiotic therapy for nosocomial pneumonia.
- To evaluate the efficacy and safety of inhaled antibiotics, particularly aminoglycosides.
- To discuss the advantages and disadvantages of inhaled antibiotic administration in ICUs.
Summary:
- Inhaled antibiotics, often in combination with intravenous drugs, represent a viable strategy for managing nosocomial pneumonia.
- This therapeutic approach can enhance drug delivery to the lungs, potentially overcoming systemic resistance issues.
- Aminoglycosides administered via inhalation are highlighted for their role in treating these challenging infections.
Impact:
- Provides clinicians with an evidence-based overview of inhaled antibiotic options for ICU patients.
- Highlights a promising strategy to combat antibiotic resistance in hospital-acquired infections.
- Supports the development of optimized treatment protocols for severe pneumonia in critical care settings.
More Related Videos
Related Concept Videos
01:28Pneumonia IV: Management
1.1K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
01:23Inhaled Medications
992
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
992
01:30Pneumonia I: Introduction
1.3K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
01:30Pneumonia V: Nursing management and Prevention
4.0K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.0K
01:14Atypical Pneumonia
38
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
38
01:28Pulmonary Tuberculosis V
864
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
864